CLINICAL_TRIALS
trial_result
· 2016-11-11
Clinical Trial Update: Good EULAR Response In Patients With Early Rheumatoid Arthritis
Summary
Pfizer-sponsored clinical trial in early rheumatoid arthritis reports a good EULAR response and has posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2016-11-11